Chongqing Pharscin Pharmaceutical (002907.SZ) announced that on December 12, 2024, the company participated in the national organized...
According to Zhithong Finance APP, Chongqing Pharscin Pharmaceutical (002907.SZ) announced that on December 12, 2024, the company participated in the tenth batch of national centralized procurement work organized by the National Organization for Pharmaceutical Joint Procurement Office ("Joint Procurement Office"). According to the "Proposed Selection Results Table for National Drug Centralized Procurement" (GYYD2024-2) released by the Joint Procurement Office, the company's products, Compound Polyethylene Glycol Electrolyte Powder (III) and Mesylate Resagiline Tablets, are proposed to be selected for this centralized procurement.